Chinese biotech censured for false claim on Gilead’s drug
Bloomberg A Chinese biotech company which claimed to be able to manufacture an experimental drug from Gilead Sciences Inc with the potential to treat the novel coronavirus, was censured for disclosing inaccurate information. The Shanghai Stock Exchange said in an statement that BrightGene Bio-Medical Technology Co has not gained approval from China’s drug regulator to make the drug known as ...
Read More »